nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO1B3—Liothyronine—hypothyroidism	0.116	0.128	CbGbCtD
Fexofenadine—SLCO1B3—Levothyroxine—hypothyroidism	0.116	0.128	CbGbCtD
Fexofenadine—SLCO1B3—Liotrix—hypothyroidism	0.113	0.125	CbGbCtD
Fexofenadine—SLCO1B1—Dextrothyroxine—hypothyroidism	0.0888	0.0984	CbGbCtD
Fexofenadine—SLCO1A2—Levothyroxine—hypothyroidism	0.0713	0.079	CbGbCtD
Fexofenadine—SLCO1A2—Liothyronine—hypothyroidism	0.0713	0.079	CbGbCtD
Fexofenadine—SLCO1A2—Liotrix—hypothyroidism	0.0696	0.0771	CbGbCtD
Fexofenadine—SLCO1B1—Levothyroxine—hypothyroidism	0.0673	0.0746	CbGbCtD
Fexofenadine—SLCO1B1—Liothyronine—hypothyroidism	0.0673	0.0746	CbGbCtD
Fexofenadine—SLCO1B1—Liotrix—hypothyroidism	0.0657	0.0728	CbGbCtD
Fexofenadine—ABCB1—Levothyroxine—hypothyroidism	0.0193	0.0214	CbGbCtD
Fexofenadine—ABCB1—Liothyronine—hypothyroidism	0.0193	0.0214	CbGbCtD
Fexofenadine—ABCB1—Liotrix—hypothyroidism	0.0188	0.0208	CbGbCtD
Fexofenadine—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00484	0.0577	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00238	0.0284	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00238	0.0284	CcSEcCtD
Fexofenadine—Increased appetite—Levothyroxine—hypothyroidism	0.00229	0.0274	CcSEcCtD
Fexofenadine—Increased appetite—Dextrothyroxine—hypothyroidism	0.00229	0.0274	CcSEcCtD
Fexofenadine—Tachycardia—Liothyronine—hypothyroidism	0.0021	0.0251	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Liotrix—hypothyroidism	0.00175	0.0209	CcSEcCtD
Fexofenadine—Body temperature increased—Liothyronine—hypothyroidism	0.0017	0.0203	CcSEcCtD
Fexofenadine—Increased appetite—Liotrix—hypothyroidism	0.00169	0.0201	CcSEcCtD
Fexofenadine—Loperamide—POMC—hypothyroidism	0.00161	1	CrCbGaD
Fexofenadine—Flushing—Levothyroxine—hypothyroidism	0.00138	0.0165	CcSEcCtD
Fexofenadine—Flushing—Dextrothyroxine—hypothyroidism	0.00138	0.0165	CcSEcCtD
Fexofenadine—Tension—Dextrothyroxine—hypothyroidism	0.00127	0.0152	CcSEcCtD
Fexofenadine—Tension—Levothyroxine—hypothyroidism	0.00127	0.0152	CcSEcCtD
Fexofenadine—Nervousness—Dextrothyroxine—hypothyroidism	0.00126	0.015	CcSEcCtD
Fexofenadine—Nervousness—Levothyroxine—hypothyroidism	0.00126	0.015	CcSEcCtD
Fexofenadine—Agitation—Dextrothyroxine—hypothyroidism	0.00119	0.0142	CcSEcCtD
Fexofenadine—Agitation—Levothyroxine—hypothyroidism	0.00119	0.0142	CcSEcCtD
Fexofenadine—Angioedema—Dextrothyroxine—hypothyroidism	0.00119	0.0142	CcSEcCtD
Fexofenadine—Angioedema—Levothyroxine—hypothyroidism	0.00119	0.0142	CcSEcCtD
Fexofenadine—Palpitations—Levothyroxine—hypothyroidism	0.00115	0.0137	CcSEcCtD
Fexofenadine—Palpitations—Dextrothyroxine—hypothyroidism	0.00115	0.0137	CcSEcCtD
Fexofenadine—Tachycardia—Levothyroxine—hypothyroidism	0.00103	0.0123	CcSEcCtD
Fexofenadine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00103	0.0123	CcSEcCtD
Fexofenadine—Flushing—Liotrix—hypothyroidism	0.00102	0.0121	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000965	0.0115	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000965	0.0115	CcSEcCtD
Fexofenadine—CYP2D6—urine—hypothyroidism	0.000963	0.0933	CbGeAlD
Fexofenadine—Insomnia—Levothyroxine—hypothyroidism	0.000958	0.0114	CcSEcCtD
Fexofenadine—Insomnia—Dextrothyroxine—hypothyroidism	0.000958	0.0114	CcSEcCtD
Fexofenadine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000944	0.0113	CcSEcCtD
Fexofenadine—Dyspnoea—Levothyroxine—hypothyroidism	0.000944	0.0113	CcSEcCtD
Fexofenadine—Flatulence—Liotrix—hypothyroidism	0.000941	0.0112	CcSEcCtD
Fexofenadine—SLCO1B3—pituitary gland—hypothyroidism	0.00094	0.0911	CbGeAlD
Fexofenadine—Tension—Liotrix—hypothyroidism	0.000937	0.0112	CcSEcCtD
Fexofenadine—Nervousness—Liotrix—hypothyroidism	0.000927	0.0111	CcSEcCtD
Fexofenadine—Fatigue—Levothyroxine—hypothyroidism	0.000913	0.0109	CcSEcCtD
Fexofenadine—Fatigue—Dextrothyroxine—hypothyroidism	0.000913	0.0109	CcSEcCtD
Fexofenadine—Vision blurred—Liotrix—hypothyroidism	0.0009	0.0107	CcSEcCtD
Fexofenadine—Agitation—Liotrix—hypothyroidism	0.000877	0.0105	CcSEcCtD
Fexofenadine—Angioedema—Liotrix—hypothyroidism	0.000872	0.0104	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000866	0.0103	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000866	0.0103	CcSEcCtD
Fexofenadine—Palpitations—Liotrix—hypothyroidism	0.000843	0.0101	CcSEcCtD
Fexofenadine—Urticaria—Dextrothyroxine—hypothyroidism	0.000841	0.01	CcSEcCtD
Fexofenadine—Urticaria—Levothyroxine—hypothyroidism	0.000841	0.01	CcSEcCtD
Fexofenadine—Body temperature increased—Levothyroxine—hypothyroidism	0.000837	0.00999	CcSEcCtD
Fexofenadine—Abdominal pain—Levothyroxine—hypothyroidism	0.000837	0.00999	CcSEcCtD
Fexofenadine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000837	0.00999	CcSEcCtD
Fexofenadine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000837	0.00999	CcSEcCtD
Fexofenadine—Anaphylactic shock—Liotrix—hypothyroidism	0.000779	0.0093	CcSEcCtD
Fexofenadine—Infection—Liotrix—hypothyroidism	0.000774	0.00924	CcSEcCtD
Fexofenadine—Tachycardia—Liotrix—hypothyroidism	0.00076	0.00907	CcSEcCtD
Fexofenadine—Asthenia—Dextrothyroxine—hypothyroidism	0.00076	0.00907	CcSEcCtD
Fexofenadine—Asthenia—Levothyroxine—hypothyroidism	0.00076	0.00907	CcSEcCtD
Fexofenadine—Pruritus—Dextrothyroxine—hypothyroidism	0.000749	0.00894	CcSEcCtD
Fexofenadine—Pruritus—Levothyroxine—hypothyroidism	0.000749	0.00894	CcSEcCtD
Fexofenadine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000725	0.00865	CcSEcCtD
Fexofenadine—Diarrhoea—Levothyroxine—hypothyroidism	0.000725	0.00865	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00071	0.00847	CcSEcCtD
Fexofenadine—Insomnia—Liotrix—hypothyroidism	0.000705	0.00841	CcSEcCtD
Fexofenadine—Dyspnoea—Liotrix—hypothyroidism	0.000694	0.00829	CcSEcCtD
Fexofenadine—Vomiting—Levothyroxine—hypothyroidism	0.000673	0.00804	CcSEcCtD
Fexofenadine—Vomiting—Dextrothyroxine—hypothyroidism	0.000673	0.00804	CcSEcCtD
Fexofenadine—Fatigue—Liotrix—hypothyroidism	0.000672	0.00802	CcSEcCtD
Fexofenadine—Rash—Dextrothyroxine—hypothyroidism	0.000668	0.00797	CcSEcCtD
Fexofenadine—Rash—Levothyroxine—hypothyroidism	0.000668	0.00797	CcSEcCtD
Fexofenadine—Dermatitis—Levothyroxine—hypothyroidism	0.000667	0.00796	CcSEcCtD
Fexofenadine—Dermatitis—Dextrothyroxine—hypothyroidism	0.000667	0.00796	CcSEcCtD
Fexofenadine—Headache—Dextrothyroxine—hypothyroidism	0.000663	0.00792	CcSEcCtD
Fexofenadine—Headache—Levothyroxine—hypothyroidism	0.000663	0.00792	CcSEcCtD
Fexofenadine—SLCO1B3—liver—hypothyroidism	0.000657	0.0636	CbGeAlD
Fexofenadine—Gastrointestinal pain—Liotrix—hypothyroidism	0.000637	0.0076	CcSEcCtD
Fexofenadine—Nausea—Dextrothyroxine—hypothyroidism	0.000629	0.00751	CcSEcCtD
Fexofenadine—Nausea—Levothyroxine—hypothyroidism	0.000629	0.00751	CcSEcCtD
Fexofenadine—Urticaria—Liotrix—hypothyroidism	0.000619	0.00739	CcSEcCtD
Fexofenadine—Abdominal pain—Liotrix—hypothyroidism	0.000616	0.00735	CcSEcCtD
Fexofenadine—Body temperature increased—Liotrix—hypothyroidism	0.000616	0.00735	CcSEcCtD
Fexofenadine—SLCO2B1—heart—hypothyroidism	0.000575	0.0558	CbGeAlD
Fexofenadine—Hypersensitivity—Liotrix—hypothyroidism	0.000574	0.00685	CcSEcCtD
Fexofenadine—Asthenia—Liotrix—hypothyroidism	0.000559	0.00667	CcSEcCtD
Fexofenadine—Pruritus—Liotrix—hypothyroidism	0.000551	0.00658	CcSEcCtD
Fexofenadine—Diarrhoea—Liotrix—hypothyroidism	0.000533	0.00636	CcSEcCtD
Fexofenadine—Dizziness—Liotrix—hypothyroidism	0.000515	0.00615	CcSEcCtD
Fexofenadine—Vomiting—Liotrix—hypothyroidism	0.000495	0.00591	CcSEcCtD
Fexofenadine—Rash—Liotrix—hypothyroidism	0.000491	0.00586	CcSEcCtD
Fexofenadine—Dermatitis—Liotrix—hypothyroidism	0.000491	0.00586	CcSEcCtD
Fexofenadine—Headache—Liotrix—hypothyroidism	0.000488	0.00582	CcSEcCtD
Fexofenadine—SLCO1B1—blood—hypothyroidism	0.000486	0.0471	CbGeAlD
Fexofenadine—Nausea—Liotrix—hypothyroidism	0.000463	0.00552	CcSEcCtD
Fexofenadine—SLCO2B1—adrenal gland—hypothyroidism	0.00043	0.0416	CbGeAlD
Fexofenadine—SLCO2B1—thyroid gland—hypothyroidism	0.000414	0.0402	CbGeAlD
Fexofenadine—SLCO2B1—female gonad—hypothyroidism	0.0004	0.0388	CbGeAlD
Fexofenadine—SLCO1B1—liver—hypothyroidism	0.00038	0.0368	CbGeAlD
Fexofenadine—SLCO2B1—testis—hypothyroidism	0.000355	0.0344	CbGeAlD
Fexofenadine—SLCO2B1—liver—hypothyroidism	0.000336	0.0325	CbGeAlD
Fexofenadine—SLCO2B1—cerebellum—hypothyroidism	0.000328	0.0318	CbGeAlD
Fexofenadine—SLCO1A2—testis—hypothyroidism	0.000327	0.0317	CbGeAlD
Fexofenadine—SLCO1A2—liver—hypothyroidism	0.000309	0.03	CbGeAlD
Fexofenadine—SLCO1A2—cerebellum—hypothyroidism	0.000302	0.0293	CbGeAlD
Fexofenadine—HRH1—adrenal gland—hypothyroidism	0.000242	0.0234	CbGeAlD
Fexofenadine—HRH1—female gonad—hypothyroidism	0.000226	0.0219	CbGeAlD
Fexofenadine—SLCO2B1—Transport of organic anions—AVP—hypothyroidism	0.000207	0.113	CbGpPWpGaD
Fexofenadine—HRH1—testis—hypothyroidism	0.0002	0.0194	CbGeAlD
Fexofenadine—CYP2D6—blood—hypothyroidism	0.000184	0.0178	CbGeAlD
Fexofenadine—ABCB1—adrenal cortex—hypothyroidism	0.000183	0.0178	CbGeAlD
Fexofenadine—ABCB1—heart—hypothyroidism	0.000177	0.0172	CbGeAlD
Fexofenadine—CYP2D6—female gonad—hypothyroidism	0.000172	0.0166	CbGeAlD
Fexofenadine—ABCB1—cardiovascular system—hypothyroidism	0.000167	0.0162	CbGeAlD
Fexofenadine—SLCO1B3—Transport of organic anions—AVP—hypothyroidism	0.000161	0.088	CbGpPWpGaD
Fexofenadine—CYP2D6—testis—hypothyroidism	0.000152	0.0148	CbGeAlD
Fexofenadine—ABCB1—gonad—hypothyroidism	0.000152	0.0147	CbGeAlD
Fexofenadine—ABCB1—pituitary gland—hypothyroidism	0.000148	0.0144	CbGeAlD
Fexofenadine—CYP2D6—liver—hypothyroidism	0.000144	0.0139	CbGeAlD
Fexofenadine—CYP2D6—cerebellum—hypothyroidism	0.000141	0.0136	CbGeAlD
Fexofenadine—ABCB1—adrenal gland—hypothyroidism	0.000132	0.0128	CbGeAlD
Fexofenadine—ABCB1—blood—hypothyroidism	0.000132	0.0128	CbGeAlD
Fexofenadine—ABCB1—thyroid gland—hypothyroidism	0.000128	0.0124	CbGeAlD
Fexofenadine—SLCO1A2—Transport of organic anions—AVP—hypothyroidism	0.000127	0.0692	CbGpPWpGaD
Fexofenadine—ABCB1—female gonad—hypothyroidism	0.000123	0.012	CbGeAlD
Fexofenadine—ABCB1—testis—hypothyroidism	0.00011	0.0106	CbGeAlD
Fexofenadine—SLCO1B1—Transport of organic anions—AVP—hypothyroidism	0.000108	0.0591	CbGpPWpGaD
Fexofenadine—ABCB1—liver—hypothyroidism	0.000104	0.01	CbGeAlD
Fexofenadine—ABCB1—cerebellum—hypothyroidism	0.000101	0.0098	CbGeAlD
Fexofenadine—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	7.67e-05	0.0418	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	5.99e-05	0.0326	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	5.23e-05	0.0285	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	4.7e-05	0.0257	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	4.33e-05	0.0236	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	4.08e-05	0.0223	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	4.02e-05	0.0219	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	3.38e-05	0.0185	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	3.21e-05	0.0175	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	2.74e-05	0.015	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	2.66e-05	0.0145	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	2.66e-05	0.0145	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	2.27e-05	0.0124	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.2e-05	0.012	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	2.09e-05	0.0114	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	2.08e-05	0.0113	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	1.72e-05	0.00938	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—TRH—hypothyroidism	1.7e-05	0.00927	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	1.65e-05	0.00898	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	1.63e-05	0.0089	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	1.63e-05	0.00889	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	1.52e-05	0.00829	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—IYD—hypothyroidism	1.4e-05	0.00765	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	1.39e-05	0.00761	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	1.35e-05	0.00737	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—AVP—hypothyroidism	1.29e-05	0.00701	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	1.28e-05	0.007	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ATP5O—hypothyroidism	1.19e-05	0.0065	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	1.16e-05	0.0063	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	1.13e-05	0.00614	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—TPO—hypothyroidism	1.12e-05	0.00611	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—IYD—hypothyroidism	1.1e-05	0.00601	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	1.1e-05	0.00598	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.06e-05	0.00579	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.04e-05	0.00567	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	1.01e-05	0.00551	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	1e-05	0.00547	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	1e-05	0.00547	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—IYD—hypothyroidism	9.42e-06	0.00514	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ATP5O—hypothyroidism	9.37e-06	0.00511	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—AVP—hypothyroidism	8.93e-06	0.00487	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TPO—hypothyroidism	8.81e-06	0.0048	CbGpPWpGaD
Fexofenadine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.75e-06	0.00477	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	8.64e-06	0.00471	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—TRH—hypothyroidism	8.57e-06	0.00467	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—AVP—hypothyroidism	8.37e-06	0.00456	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.3e-06	0.00452	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.16e-06	0.00445	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ATP5O—hypothyroidism	8.01e-06	0.00437	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	7.98e-06	0.00435	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—TSHB—hypothyroidism	7.64e-06	0.00417	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—TSHR—hypothyroidism	7.64e-06	0.00417	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TPO—hypothyroidism	7.53e-06	0.00411	CbGpPWpGaD
Fexofenadine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.09e-06	0.00387	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.98e-06	0.00381	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.98e-06	0.00381	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—AVP—hypothyroidism	6.53e-06	0.00356	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.52e-06	0.00355	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	5.91e-06	0.00322	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.79e-06	0.00315	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.57e-06	0.00304	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—TSHB—hypothyroidism	5.19e-06	0.00283	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—AVP—hypothyroidism	5.13e-06	0.0028	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—TRH—hypothyroidism	4.84e-06	0.00264	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—IYD—hypothyroidism	4.72e-06	0.00257	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3C2A—hypothyroidism	4.63e-06	0.00252	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.57e-06	0.00249	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—AVP—hypothyroidism	4.5e-06	0.00246	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—IYD—hypothyroidism	4.45e-06	0.00242	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—TRH—hypothyroidism	4.4e-06	0.0024	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.39e-06	0.00239	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	4.32e-06	0.00235	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	4.32e-06	0.00235	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TSHB—hypothyroidism	4.08e-06	0.00222	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ATP5O—hypothyroidism	4.01e-06	0.00219	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.93e-06	0.00214	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—TSHB—hypothyroidism	3.92e-06	0.00214	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—TSHR—hypothyroidism	3.92e-06	0.00214	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—SLC5A5—hypothyroidism	3.89e-06	0.00212	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ATP5O—hypothyroidism	3.78e-06	0.00206	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TPO—hypothyroidism	3.77e-06	0.00206	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—POMC—hypothyroidism	3.77e-06	0.00205	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3C2A—hypothyroidism	3.64e-06	0.00198	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.59e-06	0.00196	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TPO—hypothyroidism	3.55e-06	0.00194	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.54e-06	0.00193	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TSHB—hypothyroidism	3.49e-06	0.0019	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	3.11e-06	0.0017	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.07e-06	0.00167	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—SLC5A5—hypothyroidism	3.05e-06	0.00166	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CLTC—hypothyroidism	3.01e-06	0.00164	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—POMC—hypothyroidism	2.99e-06	0.00163	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.79e-06	0.00152	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	2.64e-06	0.00144	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	2.61e-06	0.00142	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TRH—hypothyroidism	2.6e-06	0.00142	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AVP—hypothyroidism	2.54e-06	0.00139	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—VAV3—hypothyroidism	2.4e-06	0.00131	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TSHB—hypothyroidism	2.32e-06	0.00126	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TSHR—hypothyroidism	2.32e-06	0.00126	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AVP—hypothyroidism	2.31e-06	0.00126	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.2e-06	0.0012	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SH2B3—hypothyroidism	2.06e-06	0.00113	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—POMC—hypothyroidism	2.03e-06	0.00111	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TSHB—hypothyroidism	1.75e-06	0.000952	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—POMC—hypothyroidism	1.69e-06	0.000922	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TSHB—hypothyroidism	1.65e-06	0.000897	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—POMC—hypothyroidism	1.6e-06	0.000871	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.56e-06	0.000849	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—POMC—hypothyroidism	1.54e-06	0.000837	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRL—hypothyroidism	1.53e-06	0.000835	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.47e-06	0.0008	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VAV3—hypothyroidism	1.42e-06	0.000773	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—POMC—hypothyroidism	1.37e-06	0.000745	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AVP—hypothyroidism	1.36e-06	0.000744	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.31e-06	0.000713	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.23e-06	0.000672	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—POMC—hypothyroidism	9.07e-07	0.000495	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1—hypothyroidism	8.72e-07	0.000476	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—POMC—hypothyroidism	6.84e-07	0.000373	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—POMC—hypothyroidism	6.44e-07	0.000351	CbGpPWpGaD
